Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: A better view of the J3 case. D2006, SGE1 - Mark
7
Dec 25, 2008 09:28AM

Dec 26, 2008 05:11AM

Dec 26, 2008 05:44AM
3
Dec 26, 2008 06:57AM
7
Dec 26, 2008 08:26AM
2
Dec 26, 2008 08:51AM
5
Dec 26, 2008 09:17AM
7
Dec 26, 2008 09:35AM
4
Dec 26, 2008 09:39AM
1
Dec 26, 2008 10:24AM
5
Dec 26, 2008 10:45AM
5
Dec 26, 2008 10:49AM
2
Dec 26, 2008 11:51AM
1
Dec 26, 2008 12:44PM

Dec 26, 2008 04:44PM

Dec 26, 2008 06:12PM
3
Dec 27, 2008 03:46AM
10
Dec 28, 2008 01:50PM
3
Dec 31, 2008 07:21AM

So it appears that what you're suggesting is that the J2.5 got ALL their chips from Intel, AMD, HP or some other(s) already MMP-licensed chip supplier.

Your last post (to which this replies) did respond to my suggested approach for "backing into" some sort of validation of your conjecture that we settled for peanuts with the J2.5 because of the pending expected result of LG/Quanta, in that subsequent licensees would have only "gotten off the hook" if they got ALL of their chips from a prior MMP licensee. But this works both ways..... Did/do the J2.5 get ALL of their chips exclusively from Intel, AMD, HP and/or some other(s) prior MMP licensee chip manufacturer?

Get my point? Your conjecture only holds water if the answer to the above question is "yes". Though I do believe/KNOW that Intel particularly was a high-volume supplier, I find it difficult to believe that Intel was their sole source supplier (for one thing, from a logistics perspective, in a high volume industry you typically want to foster multple suppliers), but they could have been. I do have to add that volume would be a consideration (i.e., perhaps other suppliers at low volume, hence lesser magnitude of infringement).

Just a friendly argument.....

SGE

Share
New Message
Please login to post a reply